首页> 外文期刊>Journal of aerosol medicine and pulmonary drug delivery >Considerations for Designing In Vitro Bioequivalence (IVBE) Studies for Pressurized Metered Dose Inhalers (pMDIs) with Spacer or Valved Holding Chamber (S/VHC) Add-on Devices
【24h】

Considerations for Designing In Vitro Bioequivalence (IVBE) Studies for Pressurized Metered Dose Inhalers (pMDIs) with Spacer or Valved Holding Chamber (S/VHC) Add-on Devices

机译:设计带有间隔器或带阀容纳室(S / VHC)附加装置的加压计量吸入器(pMDI)的体外生物等效性(IVBE)研究的设计注意事项

获取原文
获取原文并翻译 | 示例
       

摘要

Background: The choice of analytical test methods and associated statistical considerations are considered for the laboratory testing of pressurized metered dose inhaler-spacer/valved holding chamber (pMDI-S/VHC) combinations for in vitro bioequivalence (IVBE). Methods: Four scenarios are presented for comparing TEST (second entry or generic) versus REF (innovator): (1) innovator and second entry product pMDI alone without any S/VHC (baseline comparison); (2) innovator and second entry pMDI product with the same S/VHC; (3) innovator pMDI product with existing S/VHC and second entry product with a different S/VHC; and (4) introduction of a second, different S/VHC to be used with a given innovator pMDI product. The following aspects should be reviewed in the preparatory stage of designing experiments to establish IVBE: (a) the inclusion of delayed inhalation; (b) the utilization of age-appropriate flow rates; and (c) the use of anatomically appropriate face models for evaluation of devices with a facemask. Statistical considerations that fit in with such experimental methods include: selection of pMDI batches and S/VHC lots; choice of sample size and acceptance criteria; bracketing or worst case approaches; and balanced/paired designs. A stepwise approach for selection of impactor stage groupings is presented, and an approach to determine realistic acceptance criteria based on REF product characteristics is suggested. Results: An example of an efficient statistical design of experiment is provided for each scenario, together with alternate approaches for calculation of confidence intervals for the mean TEST/REF relationship. It is important to appreciate that the optimal design depends on balancing numerous considerations and will thus likely differ from case to case; hence, the designs presented here should be seen as illustrations rather than the only option available. More effective approaches may be found that suit a particular case at hand. Conclusions: The information provided will assist in developing correlations in support of IVBE for these add-on devices.
机译:背景:对于体外生物等效性(IVBE)的加压计量吸入器-隔离器/阀式容纳室(pMDI-S / VHC)组合的实验室测试,应考虑选择分析测试方法和相关的统计考虑因素。方法:提出了四种方案来比较TEST(第二次进入或通用)与REF(创新者):(1)仅创新者和第二次进入产品pMDI,没有任何S / VHC(基线比较); (2)具有相同S / VHC的创新者和第二次进入pMDI产品; (3)具有现有S / VHC的创新性pMDI产品和具有不同S / VHC的第二次进入产品; (4)引入第二种不同的S / VHC,与给定的创新者pMDI产品一起使用。在建立IVBE的设计实验的准备阶段应审查以下方面:(a)包括延迟吸入; (b)利用适合年龄的流速; (c)使用适合解剖学的面部模型评估带有面罩的设备。符合此类实验方法的统计考虑因素包括:选择pMDI批次和S / VHC批次;选择样本量和接受标准;包围或最坏情况下的方法;和平衡/配对设计。提出了一种选择冲击器阶段分组的逐步方法,并提出了一种基于REF产品特性确定现实可接受标准的方法。结果:为每种情况提供了一个有效的统计实验设计示例,以及用于计算平均TEST / REF关系的置信区间的替代方法。重要的是要意识到,最佳设计取决于多种考虑之间的平衡,因此可能因情况而异。因此,此处介绍的设计应视为说明,而不是唯一的可用选项。可能会找到适合当前特定情况的更有效方法。结论:提供的信息将有助于开发相关性,以支持这些附加设备的IVBE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号